Ionis Pharmaceuticals Inc.

IONS Nasdaq SEC CIK 874015
Follow Ionis Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $242.7M +54.9% vs same quarter last year
Net income −$110M +14.5% vs same quarter last year
EPS, diluted −$0.66 +17.5% vs same quarter last year
Operating cash flow −$179.4M −36.5% vs same quarter last year
Revenue by quarter
$226.6M
$131.6M
$452M
$156.7M
$203.3M
$246.1M
$267.9M
$242.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$943.7M−$381.4M
FY24$705.1M−$453.9M
FY23$787.6M−$366.3M
FY22$587.4M−$269.7M
FY21$810.5M−$28.6M
FY20$729.3M−$444.3M
FY19$1.1B$278.1M
FY18$599.7M$273.7M
FY17$514.2M$346K
FY16$372.8M−$60.4M
FY15$283.7M−$88.3M
FY14$214.2M−$39M
FY13$147.3M−$60.6M
FY12$102M−$65.5M
FY11$99.1M−$84.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2598.3%−40.4%−40.4%
FY2498.4%−67.4%−64.4%
FY2398.8%−44.9%−46.5%
FY2297.6%−69.8%−45.9%
FY2198.7%−3.7%−3.5%
FY2098.4%−23.6%−60.9%
FY1999.6%32.6%24.8%
FY1899.7%−10.2%45.6%
FY17100%6%0.1%
FY16100%−5.4%−16.2%
FY15-−26.7%−31.1%
FY14-−22.3%−18.2%
FY13-−35.1%−41.2%
FY12-−67.5%−64.2%
FY11-−71.8%−85.6%
Free cash flowOperating cash flow minus capital expenditure
−$1B−$500M$0$500M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$320M
FY24−$546.2M
FY23−$331.3M
FY22−$290.1M
FY21$18.8M
FY20$772K
FY19$314.7M
FY18$589.3M
FY17$139.4M
FY16−$119.2M
FY15$13.4M
FY14−$1.2M
FY13$61.9M
FY12$397K
FY11−$125M
Returned to shareholdersDividends paid and shares bought back
$0$25M$50M$75M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23-
FY22$0
FY21$0
FY20$90.5M
FY19$34.4M
FY18$0
FY17$0
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ionis Pharmaceuticals
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearIonis PharmaceuticalsHealthcare median
FY25−40.4%−30.6%
FY24−64.4%−47%
FY23−46.5%−58%
FY22−45.9%−80.4%
FY21−3.5%−71.9%
FY20−60.9%−62.2%
FY1924.8%−46.3%
FY1845.6%−49.6%
FY170.1%−45.9%
FY16−16.2%−36%
FY15−31.1%−38.4%
FY14−18.2%−35.5%
FY13−41.2%−37.1%
FY12−64.2%−29.1%
FY11−85.6%−27.9%